Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonist in patients with atrial fibrillation and chronic kidney disease stages IV and V: systematic review and meta-analysis

Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonist in patients with atrial fibrillation and chronic kidney disease stages IV and V: systematic review and meta-analysis

Aim. This study aims to compare efficacy and safety of direct oral anticoagulants (DOAC) with vitamin K antagonist (VKA) in patients with atrial fibrillation (AF) and chronic kidney disease (CKD) stages IV and V.Material and methods. We systematically searched the PubMed, Google Scholar, Web of Scie...

Full description

Saved in:
Bibliographic Details
Main Authors: E. G. Skorodumova, A. Yu. Suvorov, S. T. Enginoev, M. A. Kercheva, M. A. Grebenuk
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2023-07-01
Series:Российский кардиологический журнал
Subjects:
vitamin k antagonist
direct oral anticoagulants
rivaroxaban
terminal renal failure
atrial fibrillation
chronic kidney disease
Online Access:https://russjcardiol.elpub.ru/jour/article/view/5307
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items